Statins May Cut Parkinson's Disease Risk, Harvard School of Public Health Study

Regular use of cholesterol-lowering statin drugs may lower risk of developing Parkinson's disease, shows study published in Archives of Neurology. Statins are one of the most prescribed classes of drugs in the United States and some researchers have hypothesized that the anti-inflammatory and immunomodulating effects of these medications may be neuroprotective. However, statins also may have unfavorable effects on lowering the level of plasma coenzyme Q10, which may be neuroprotective in patients with Parkinson disease (PD), the researchers write in their study background.

Back to news